NutraCea files for Chapter 11 bankruptcy

By Caroline Scott-Thomas

- Last updated on GMT

Related tags Rice

Rice bran ingredient supplier NutraCea filed for Chapter 11 bankruptcy on Tuesday, claiming that it will allow the company to restructure, reduce overheads and sell non-core assets.

The company said that it intends to focus on its core business of stabilized rice bran, rice bran oil, nutraceuticals and baby cereal. It also said that none of its subsidiaries have been included in the bankruptcy.

NutraCea added that it intends to emerge from the process as soon as possible, and in a stronger position than before the filing, although it has not put a fixed time period on how long this might take. The company listed total assets of $83.7m and total debts of $18.9m in court papers.

CEO W. John Short said: "The court-supervised restructuring process available under Chapter 11 of the US Bankruptcy Code allows NutraCea to gain immediate liquidity and continue operating without interruption, while providing the opportunity to reorganize our operations, strengthen our business performance and create long-term value for our stakeholders."

NutraCea has also secured extra debtor-in-possession (DIP) financing of $6.75m from Wells Fargo Bank to allow it to continue with its day-to-day operations while it carries out its restructuring plans under Chapter 11. It already owes Wells Fargo $3.575m under an existing credit facility.

Short said: “We will work hard to emerge from this process as quickly as possible with a streamlined cost structure that should allow us to operate as a healthier, more competitive and profitable company. We deeply appreciate the dedication and efforts of our employees, who have worked exceedingly hard during this challenging period. We look forward to the continued support of our customers, vendors and business partners as we reposition NutraCea for future growth and profitability."

The company said that its business operations have been “impaired by tight liquidity” ​but that the DIP financing as well as income from continuing business should see it better prepared to return to more normal daily business interactions while it reorganizes its operations.

NutraCea had previously said that 2008 had been a challenging year, and that it intended to sell assets and increase revenues in order to provide cash for continuing operations. In the past, it had looked to equity funds for additional liquidity but due to the company’s financial position and the state of equity markets it was unable to turn to them for funding at this time.

Related news

Show more

Related products

show more

Bacillus coagulans SNZ 1969

Bacillus coagulans SNZ 1969

B&D Nutritional Ingredients | 25-Jan-2023 | Technical / White Paper

Bacillus coagulans SNZ 1969TM is an exceptional probiotic strain due to its stability, 50-year history of use and efficacy supported by twenty plus publications.

Withania Somnifera (Ashwagandha) - For Better Health

Withania Somnifera (Ashwagandha) - For Better Health

Chemical Resources (CHERESO) | 16-Jan-2023 | Technical / White Paper

Withania somnifera (Ashwagandha) is one of the few herbs with significant effects on both psychological and physiological aspects of human functioning.

T. Hasegawa releases 2023 Flavor Trends Report

T. Hasegawa releases 2023 Flavor Trends Report

T. Hasegawa USA | 10-Jan-2023 | Insight Guide

When it comes to flavor, 2023 promises more exciting experiences in food and beverage than ever before. Analyzing the “Now, Near and Next” of consumer...

Withania Somnifera (Ashwagandha) - For Better Health

Withania Somnifera (Ashwagandha) - For Better Health

Chemical Resources (CHERESO) | 03-Jan-2023 | Technical / White Paper

Withania somnifera (Ashwagandha) is one of the few herbs with significant effects on both psychological and physiological aspects of human functioning.

Related suppliers

Follow us

Products

View more

Webinars